Long-term morbidity and mortality trials with amlodipine

Journal of Cardiovascular Pharmacology

Volumn 33, Issue SUPPL. 2, 1999, Pages

  Oparil, Suzanne ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Amlodipine; Calcium antagonist; Coronary artery disease; Hypertension; Ischemia

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; CLONIDINE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; HYDRALAZINE; LISINOPRIL; METOPROLOL; PERINDOPRIL; RAMIPRIL; RESERPINE;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMBINATION CHEMOTHERAPY; CONGESTIVE HEART FAILURE; DIET THERAPY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; ERECTILE DYSFUNCTION; ESSENTIAL HYPERTENSION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERCHOLESTEROLEMIA; KIDNEY DISEASE; LONG TERM CARE; METABOLIC DISORDER; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

AMLODIPINE; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CLINICAL TRIALS; HUMANS; HYPERTENSION;

EID: 0033047620     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199906003-00001     Document Type: Review

References (25)

1. MacMahon S, Peto R, Culter J, et al. Blood pressure, stroke, coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective, observational studies corrected for the regression dilution bias. Lancet 1990;335:765-74.
2. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990;335:827-38.
3. Cohen JD, Neaton JD, Prineas RJ, Daniels KA, for the MRFIT Research Group. Diuretics, serum potassium, and ventricular arrhythmias in the Multiple Risk Factor Intervention Trial. Am J Cardiol 1987;69:548-54.
4. Ferrari P, Rosman J, Weidman P. Antihypertensive agents, serum lipoproteins, and glucose metabolism. Am J Cardiol 1991;67:26B-35B.
5. Siscovick DS, Raghunathan TE, Psaty BM, et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994;330:1852-7.
6. Jerome M, Xakellis JC, Angstman G, Patchin W. Initial medication selection for treatment of hypertension in an open-panel HMO. J Am Board Fam Pract 1995;8:1-6.
7. Neaton JD, Grimm RH Jr, Prineas RJ, et al. Treatment of Mild Hypertension Study Research Group: treatment of mild hypertension study: final results. JAMA 1993;270:713-24.
8. Materson BJ, Reda DJ, Cushman WC, et al. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents: single-drug therapy for hypertension in men, a comparison of six antihypertensive agents with placebo. N Engl J Med 1993;328:914-21.
9. Davis BR, Cutler JA, Gordon DJ, et al. Rationale and design for the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT). Am J Hypertens 1996;9:342-60.
10. Dunnett CW. A multiple comparisons procedure for comparing several treatments with a control. J Am Stat Assoc 1995;60:573-83.
11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) JAMA 1993;269:3015-23.
12. Barjon JN, Rouleau J-L, Bichet D, et al. Chronic renal and neurohormonal effects of the calcium entry blocker nisoldipine in patients with congestive heart failure. J Am Coll Cardial 1987;9: 622-30.
13. Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988;319:385-92.
14. Elkayam U, Amin J, Mehra A, et al. A prospective randomized, double-blind crossover study to compare the efficacy and safety of chronic nifedipine therapy to isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation 1990;82:1954-62.
15. Goldstein RE, Boccuzzi SJ, Cruess D, Nattel S, and the Adverse Experience Committee and the Multicenter Diltiazem Postinfarction Research Group. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. Circulation 1991;83:52-60.
16. Packer M. Calcium-channel blockade in the management of severe chronic congestive heart failure: a bridge too far. Circulation 1987;75(Suppl V):56-64.
17. Packer M, Nicod P, Khandheria BR, et al. Randomized, multi-center, double-blind, placebo-controlled evaluation of amlodipine in patients with mild-to-moderate heart failure [Abstract]. J Am Coll Cardiol 1991;17;274A.
18. Smith WB, DeAbate AC, Gollub SB, et al. Beneficial long-term hemodynamic and clinical effects of amlodipine in chronic heart failure: results of a multicenter randomized, double-blind, placebo-controlled, dose-ranging study [Abstract]. Circulation 1994;90:I-603.
19. Packer M, O'Connor CM, Ghali JK, et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996;335:1107-14.
20. Ferlinz J, Gallo CT. Responses in patients in heart failure to long-term oral verapamil administration [Abstract]. Circulation 1984;70:11-305.
21. Packer M. Pathophysiologic mechanisms underlying the adverse effects of calcium channel blocking drugs in patients with chronic heart failure. Circulation 1989;80(Suppl IV):59-67.
22. Cohn JN, Ziesche S, Smith R, et al. Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril. Circulation 1997;96:856-63.
23. Littler WA, Sheridan DJ. Placebo controlled trial of felodipine in patients with mild to moderate heart failure: UK Study Group. Br Heart J 1995;73:428-33.
24. Singh SN, Fletcher RD, Fisher SG, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmias. Survival Trial of Anti-arrhythmic Therapy in Congestive Heart Failure. N Engl J Med 1995;333:77-82.
25. CIBIS Investigators and Committees. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1994;90:1765-73.